Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
This retrospective study evaluated the impact of intermediate Recurrence Score® results on adjuvant treatment decisions in estrogen receptor-positive (ER+) early invasive breast cancer, comparing treatment recommendations pre-testing with actual treatments received post-testing. Of the 111 patients...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925494/ |